Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
144.7 DKK | +0.70% | -5.76% | +42.39% |
06-04 | Transcript : ALK-Abelló A/S - Analyst/Investor Day | |
06-03 | ALK Presents Positive Phase 3 Paediatric Trial Data Offering New Hope for Children with Respiratory Allergy | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ALK-ABELLÓ A/S | Other Pharmaceuticals | +0.28% | -5.76% | +42.39% | +65.16% | +82.98% | 4.6B |
- Stock Market
- Equities
- ALK B Stock
- Charts ALK-Abelló A/S
- Relative Strength Chart